溶解体EGFR作为Rheb-GEF独立于其激酶活性来激活mTORC1的作用
Xiaobo He1, Qiu-Xia Wang1, Denghui Wei2
1Sun Yat-sen University Cancer Center, Guangdong Provincial Clinical Research Center for Cancer, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, China.
Cell research
|April 21, 2025
概括
皮表皮生长因子受体 (EGFR) 具有一种新的激酶独立功能,通过结合Rheb.激活mTORC1. 针对这种机制,与激酶活性一起,提供了一个有前途的癌症治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 分子瘤学分子瘤学
- 信号传输 信号传输
背景情况:
- 皮表皮肤生长因子受体 (EGFR) 的致癌突变通过促进构成性激活和异常信号传递来驱动癌症.
- EGFR突变激活了拉巴胺素复合体1 (mTORC1) 信号传递的机械标,增加了细胞增殖,但酶独立的作用正在出现.
- EGFR在细胞存活和癌症进展中的作用超出了其激酶活性,需要更深入地了解其功能.
研究的目的:
- 为了研究 EGFR. 激活 mTORC1 的一种新的,与激酶无关的机制.
- 阐明EGFR在mTORC1激活中的 lysosomal定位的作用.
- 探索针对突变EGFR的酶和非酶功能的治疗策略.
主要方法:
- 研究了EGFR与Rheb在 lysosome上的相互作用.
- 使用基因敲门模型 (EGFR-E804K) 来评估Rheb-GTP水平和mTORC1激活.
- 评估了氨酸激酶抑制剂 (阿法替尼,埃洛替尼) 和针对EGFR功能的一种新型小分子 (BIEGi-1) 的疗效.
主要成果:
- 通过在 lysosome 处与 Rheb 的物理结合,EGFR 直接激活 mTORC1 独立于其激酶活性.
- EGFR的Glu804残留物对于其对Rheb.的关氨酸交换因子 (GEF) 活性至关重要.
- 对EGFR的GEF活性 (EGFR-E804K) 的遗传干扰显著降低了mTORC1激活,细胞增殖和瘤生长.
- 与埃洛尼布相比,阿法尼布通过阻断酶和GEF活动,表现出更好的mTORC1和细胞生长的抑制.
- 新型小分子BIEGi-1,针对EGFR的两个活动,强烈抑制EGFR突变癌细胞的活力.
结论:
- EGFR在激素酶上通过Rheb GEF活性激活mTORC1方面具有关键的,与激酶独立的功能.
- 针对突变EGFR的酶和Rheb-GEF活动,代表了针对由EGFR突变驱动的癌症的强有力的治疗策略.
- 这一发现为细胞生长调节提供了基本的洞察力,并为瘤学中的合理药物设计开辟了新的途径.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
MAPK Signaling Cascades
4.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
4.9K
Small GTPases - Ras and Rho
3.8K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.8K
Receptor Tyrosine Kinases
11.7K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
11.7K


